Literature DB >> 12765757

Insight and neurocognition in schizophrenia.

Richard James Drake1, Shôn William Lewis.   

Abstract

The relationship between neurocognitive impairments in schizophrenia remains unclear. Recent literature was reviewed and the most consistent finding was an association between perseverative errors on the Wisconsin Card Sort Test (WCST) and poor insight. The aim was to confirm and extend this finding using a range of assessments relevant to perseveration, and different dimensions of insight, in a sample of 33 acutely psychotic subjects within 5 years of onset of schizophrenia and related disorders. Results showed a correlation (r=-0.59) between insight and perseverative errors, rather than more general measures of abstraction. A factor representing relabelling symptoms, derived from insight scale items, correlated even more strongly; however, other insight factors correlated more weakly, suggesting they are less dependent on neuropsychological deficits. The ability to monitor output and correct errors appears to be closely related to the core features of insight in psychosis.

Entities:  

Mesh:

Year:  2003        PMID: 12765757     DOI: 10.1016/s0920-9964(02)00382-1

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  26 in total

Review 1.  Real-world cognitive--and metacognitive--dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff".

Authors:  Danny Koren; Larry J Seidman; Morris Goldsmith; Phillip D Harvey
Journal:  Schizophr Bull       Date:  2006-01-05       Impact factor: 9.306

2.  Insight and regional brain volumes in schizophrenia.

Authors:  Débora Pastore Bassitt; Mario Rodrigues Louzä Neto; Cláudio Campi de Castro; Geraldo F Busatto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-02       Impact factor: 5.270

3.  Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness.

Authors:  Piotr J Quee; Lisette van der Meer; Richard Bruggeman; Lieuwe de Haan; Lydia Krabbendam; Wiepke Cahn; Niels C L Mulder; Durk Wiersma; André Aleman
Journal:  Schizophr Bull       Date:  2010-11-22       Impact factor: 9.306

Review 4.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

5.  Theory of mind and unawareness of illness in schizophrenia: is poor insight a mentalizing deficit?

Authors:  Emre Bora; Gulsah Sehitoglu; Mustafa Aslier; Ihsan Atabay; Baybars Veznedaroglu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-14       Impact factor: 5.270

6.  White matter integrity and lack of insight in schizophrenia and schizoaffective disorder.

Authors:  Daniel Antonius; Vasthie Prudent; Yasmina Rebani; Debra D'Angelo; Babak A Ardekani; Dolores Malaspina; Matthew J Hoptman
Journal:  Schizophr Res       Date:  2011-03-22       Impact factor: 4.939

7.  Insight in schizophrenia: associations with empathy.

Authors:  G H M Pijnenborg; J M Spikman; B F Jeronimus; A Aleman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-10-18       Impact factor: 5.270

8.  Lack of relationship between psychological denial and unawareness of illness in schizophrenia-spectrum disorders.

Authors:  Carrie L Kruck; Laura A Flashman; Robert M Roth; Nancy S Koven; Thomas W McAllister; Andrew J Saykin
Journal:  Psychiatry Res       Date:  2009-07-17       Impact factor: 3.222

9.  The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life.

Authors:  A Karow; F-G Pajonk; J Reimer; F Hirdes; C Osterwald; D Naber; S Moritz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.270

10.  Taking the perspective of the other contributes to awareness of illness in schizophrenia.

Authors:  Robyn Langdon; Philip Ward
Journal:  Schizophr Bull       Date:  2008-05-20       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.